Johnson Chemical Pharmaceutical Works Co., Ltd. (TPEX:4747)

Market Cap	3.27B
Revenue (ttm)	611.42M
Net Income (ttm)	84.12M
Shares Out	44.93M
EPS (ttm)	1.86
PE Ratio	39.14
Forward PE	n/a
Dividend	1.50 (2.06%)
Ex-Dividend Date	Jun 21, 2024

Volume	176,161
Average Volume	220,585
Open	70.30
Previous Close	70.30
Day's Range	70.10 - 72.80
52-Week Range	61.20 - 88.30
Beta	-0.38
RSI	34.97
Earnings Date	Mar 28, 2025

About TPEX:4747

Johnson Chemical Pharmaceutical Works Co., Ltd. manufactures, imports, and sells pharmaceutical ingredients, materials, and products in Taiwan. The company offers its products in various therapeutic areas, including central nervous system, respiratory, cardiovascular, gastrointestinal, endocrine system, vitamin, anti-inflammatory, cough and cold, pain reliever, etc. It provides its products in the solid dosage form, capsule, tablet, and powder and granule, as well as nasal spray forms. Johnson Chemical Pharmaceutical Works Co., Ltd. was founded...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1959
• Employees: 167
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 4747

Financial Performance

In 2024, TPEX:4747's revenue was 611.42 million, an increase of 0.78% compared to the previous year's 606.71 million. Earnings were 84.12 million, an increase of 5.55%.